Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

著者: François Raffi, Anita Rachlis, Hans‐Jürgen Stellbrink, W. D. Hardy, Carlo Torti, Chloe Orkin, Mark Bloch, Daniel Podzamczer, Vadim Pokrovsky, Federico Pulido, Steve Almond, David M. Margolis, Clare Brennan, Sherene Min - The Lancet 2013 被引用: 546